A weight-loss intervention program designed for Mexican-American women: cultural adaptations and results.
Lindberg NM, Stevens VJ, Vega-López S, Kauffman TL, Calderón MR, Cervantes MA.
J Immigr Minor Health. 2012 Dec;14(6):1030-9.
Cost-effectiveness analysis of screening for KRAS and BRAF mutations in metastatic colorectal cancer.
Behl AS, Goddard KA, Flottemesch TJ, Veenstra D, Meenan RT, Lin JS, Maciosek MV.
Journal of the National Cancer Institute 2012 Dec 5;104(23):1785-95. PMCID: PMC3514165
Utilization of HER2 genetic testing in a multi-institutional observational study.
Goddard KA, Aiello Bowles EJ, Spencer Feigelson H, Habel LA, Alford SH, McCarty CA, Nekhlyudov L, Onitilo AA, Rahm AK, Webster JA.
American Journal of Managed Care 2012 Nov;18(11):704-12. PMCID: PMC4061608
Genetic load is associated with hypothalamic-pituitary-adrenal axis dysregulation in macaques.
Ferguson B, Hunter JE, Luty J, Street SL, Woodall A, Grant KA.
Genes Brain Behav 2012 Nov;11(8):949-57.
Epub 2012 Oct 13. PMCID: PMC3595329.
Evaluating genomic tests from bench to bedside: A practical framework.
Lin JS, Thompson M, Goddard KAB, Piper MA, Heneghan C, Whitlock E.
BMC Med Inform Decis Mak 2012 Oct 19;12(1):117.
PMCID: PMC3538070
Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: A retrospective cohort study.
Bowles EJA, Wellman R, Feigelson HS, Onitilo A, Freedman AN, Delate T, Allen L, Nekhlyudov L, Goddard KAB, Davis R, Habel L, Yood MU, McCarty C, Magid D, Wagner EH; for the Pharmacovigilance Research Group.
JNCI 2012 Sep 5;104(17):1293-305.
PMCID: PMC3433392
Identification of nephropathy candidate genes by comparing sclerosis-prone and sclerosis-resistant mouse strain kidney transcriptomes.
El-Meanawy A, Schelling JR, Iyengar SK, Hayden P, Barathan S, Goddard K, Pozuelo F, Elashi E, Nair V, Kretzler M, Sedor J.
BMC Nephrol 2012 Jul 19;13(1):61.
PMCID: PMC3502501
Depression and anxiety symptoms among women who carry the FMR1 premutation: impact of raising a child with fragile X syndrome is moderated by CRHR1 polymorphisms.
Hunter JE, Leslie M, Novak G, Hamilton D, Shubeck L, Charen K, Abramowitz A, Epstein MP, Lori A, Binder E, Cubells JF, Sherman SL.
Am J Med Genet B Neuropsychiatr Genet 2012 Jul;159B(5):549-59.
Epub 2012 May 9. PMCID: PMC3696495.
Building the evidence base for decision making in cancer genomics using comparative effectiveness research.
Goddard KAB, Knaus WA, Whitlock E, Lyman GH, Feigelson HS, Schully S, Kushi L, Ramsey S, Tunis S, Freedman AN, Khoury MJ, Veenstra DL.
Genet Med 2012 Jul;14(7):633-42.
PMCID: PMC3632438
Stakeholder assessment of the evidence for cancer genomic tests: insights from three case studies.
Deverka PA, Schully SD, Ishibe N, Carlson JJ, Freedman A, Goddard KAB, Khoury MJ, Ramsey S.
Genet Med 2012 Jul;14(7):656-62.
PMCID: PMC4437504
Assessment of lifetime occupational exposure in an epidemiologic study of COPD.
Graziani M, Doney B, Hnizdo E, Villnave J, Breen V, Weinmann S, Vollmer WM, McBurnie MA, Buist AS, Huemann M.
Open Epidemiol J July 2012;5(1):27-35.
Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996-2010.
Smith-Bindman R, Miglioretti DL, Johnson E, Lee C, Feigelson HS, Flynn M, Greenlee RT, Kruger RL, Hornbrook MC, Roblin D, Solberg LI, Vanneman N, Weinmann S, Williams AE.
JAMA 2012 Jun 13;307(22):2400-9.
PMCID: PMC3859870
Safety of zoster vaccine in adults from a large managed-care cohort: A Vaccine Safety Datalink study.
Tseng HF, Liu A, Sy L, Marcy SM, Fireman B, Weintraub E, Baggs J, Weinmann S, Baxter R, Nordin J, Daley MF, Jackson L, Jacobsen SJ; Vaccine Safety Datalink (VSD) Team.
J Intern Med 2012 May;271(5):510-20.
[Epub 2011 Nov 22]
The FMR1 premutation and attention-deficit hyperactivity disorder (ADHD): evidence for a complex inheritance.
Hunter JE, Epstein MP, Tinker SW, Abramowitz A, Sherman SL.
Behav Genet 2012 May;42(3):415-22.
Epub 2011 Nov 19. PMCID: PMC3696489.
Reliability of KRAS mutation testing in metastatic colorectal cancer patients across five laboratories.
Feigelson HS, Goddard KA, Johnson MA, Funk KC, Rahm AK, Kauffman TL, Chitale DA, Le Marchand L, Richards CS.
BMC Res Notes 2012 Apr 25;5(1):196.
PMCID: PMC3441241
Validity of eight integrated healthcare delivery organizations’ administrative clinical data to capture breast cancer chemotherapy exposure.
Delate T, Aiello Bowles EJ, Pardee R, Wellman R, Habel L, Ulcickas Yood M, Nekhlyudov L, Goddard KAB, Davis R, McCarty C, Adedayo O, Feigelson HS, Freml J, Wagner EH; for the PharmacoVigilance Research Group.
Cancer Epidemiol Biomarkers Prev 2012 Apr;21(4):673-80.
PMCID: PMC3319397
Capturing the fragile X premutation phenotypes: a collaborative effort across multiple cohorts.
Hunter JE, Sherman S, Grigsby J, Kogan C, Cornish K.
Neuropsychology 2012 Mar;26(2):156-64.
Epub 2012 Jan 16. PMCID: PMC3295926.
Fecal DNA testing in screening for colorectal cancer in average-risk adults. Comparative Effectiveness Review No. 52. AHRQ Publication No. 12-EHC022-EF.
Lin JS, Webber EM, Beil TL, Goddard KAB, Whitlock E.
Agency for Healthcare Research and Quality, Rockville, MD. February 2012. Available at: http://www.effectivehealthcare.ahrq.gov/reports/final.cfm.
HER2 evaluation and its impact on breast cancer treatment decisions.
Goddard KAB, Weinmann S, Richert-Boe K, Chen C, Bulkley J, Wax C.
Public Health Genomics 2012;15(1):1-10.
PMCID: PMC3225235
Tailoring of membrane proteins by alternative splicing of pre-mRNA.
Mittendorf KF, Deatherage CL, Ohi MD, Sanders CR.
Biochemistry, 2012. 51, 5541-5556.